Idexx Laboratories Inc (IDXX) Dividend History

Company News

• Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000

  Idexx Laboratories is the global leader in pet healthcare diagnostics, generating substantial recurring revenue from its installed base of diagnostic equipment. Despite its impressive growth and profitability, the company's share price has languished, presenting an opportunity for investors as management ramps up share buybacks at a historically low valuation.

  The Motley Fool
• Global Swine Healthcare Market Size To Worth USD 5.96 Billion By 2033 | CAGR of 8.16% - GlobeNewswire

  The global swine healthcare market is expected to grow from USD 2.72 billion in 2023 to USD 5.96 billion by 2033, driven by increasing demand for pork products, especially in emerging markets. The market is segmented by product (diagnostics and therapeutics) and disease (respiratory, swine dysentery, etc.), with the therapeutics segment and respiratory diseases segment expected to hold the largest shares.

  GlobeNewswire Inc.

  Featured Companies: ELAN PAHC ZTS
• Looking Into IDEXX Laboratories's Recent Short Interest - IDEXX Laboratories (NASDAQ:IDXX) - Benzinga

  IDEXX Laboratories' (IDXX) short percent of float has risen 17.34% since its last report, indicating increased bearish sentiment. The company has 2.05 million shares sold short, which is 3.18% of all regular shares available for trading.

  Benzinga
• IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds

  IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.

  Zacks Investment Research

  Featured Companies: HIMS MEDP RMD
• Tracking Ron Baron's BAMCO Portfolio - Q4 2023 Update

  BAMCO Inc.'s portfolio value sees a significant increase, while Baron Capital's mutual funds demonstrate strong alpha generation vs. benchmarks. Read more here.

  Seeking Alpha

  Featured Companies: ACGL ACGLN ACGLO ANSS CSGP FDS GWRE H IRDM IT KNSL MSCI MTD MTN TSLA